Bee Venom Pharmacopuncture: An Effective Treatment for Complex Regional Pain Syndrome

Abstract

Objectives:

Treating complex regional pain syndrome (CRPS) is difficult because it still does not have a recommended therapy. A 29-year-old man was diagnosed with CRPS after surgery on his 4^th and 5^th left toes 7 years ago. Though he had undergone diverse pain treatment, the symptoms persisted, so he visited Dunsan Korean Medicine Hospital of Daejeon University. This case report presents results on the effect of bee venom pharmacopuncture in treating patient with CRPS.

Methods:

Bee venom pharmacopuncture (BVP), 0.15 to 0.4 mL dosage, was administered at GB43. The treatment was applied each week for a total 14 times. The symptoms were evaluated using a numeric rating scale (NRS) and the dosage of pain medicine.

Results:

On the first visit, he was taking an anticonvulsant, a trycyclic antidepressant, and an analgesic. On the NRS the worst pain in the toes received a score of 8. He also complained of severe pain and hypersensitivity when the 4^th and the 5^th toes were touched just slightly. Other complaint included dyspepsia, rash, and depression. After treatment, on the NRS, the score for toe pain was 0, and he no longer needed to take pain medication. During the 4-months follow-up period, he has remained without pain; neither have additional symptoms appeared nor adverse events occurred.

Conclusion:

BVP may have potential benefits for treating patients with CRPS.

1. Introduction

Complex regional pain syndrome (CRPS) is a neuropathic pain disease, which is the name now given to group of conditions previously described as ‘reflex sympathetic dystrophy (RSD)’, ‘Causalgia’, ‘Algodystrophy’, ‘Sudeck’s atrophy’. This chronic pain syndrome appears after big and small tissue damage, such as a sprain, a fracture, neurologic damage, spinal cord injury, cerebral infarction and myocardial infarction. These conditions share a number of clinical features, including spontaneous pain that is mostly on the limbs, associated allodynia, hyperalgesia, autonomic changes, trophic changes, and functional loss [1].

The diagnosis of CRPS had been based on the criteria of the International Association for the Study of Pain published in 1994. However, due to the lack of specificity and accuracy of diagnosis, the criteria, as revised in 2004, are used instead [2].

The primary medications for treating CRPS are anti-inflammatory drugs, anticonvulsants, antidepressants, and steroids [3]. For additional pain control, nerve blocks, such as regional nerve blocks and sympathecotomies, and interventional treatment, such as spinal cord stimulation, are used together [4]. Though various remedies exist, the therapeutic responses to traditional treatments are relatively poor, and because of the complicated symptoms, a diverse approach is necessary [5].

Besides the traditional therapy, patients with CRPS recently treated in China were reported to have been improved by 80%, and that improvement continued for more than 20 months [6]. Also, chronic CRPS patients treated with acupuncture have been reported to show reduced pain and depression and enhanced quality of life [7]. In additional to international studies on acupuncture, cases using anti-inflammatory pharmacopuncture [8], Harpagophytum radix. pharmacopuncture [9], and placental extracts [10] have been reported in Korea. In this research study, we describe the case of a patient with CRPS who responded to bee venom pharmacopuncture (BVP) with impressive and sustained results.

2. Case report

This patients was a 29-year-old male with a history of congenital polysyndactylia of the 4^th and the 5^th toes. He had undergone a polydactyly resection, separation of syndactyly, and split thickness skin-graft on March 14, 2006 and surgery on the necrosis site on April 20, 2006. His mother had a history of hypertension.

After joining the army in 2006 and complaining of difficulty with military life because of the congenital polysyndactylia, he underwent resection, separation of syndactyly, on his 4^th and 5^th toes. After the surgery he reported pain and paresthesia on those toes and was diagnosed with CRPS; however, according to the operation notes, no neurologic damage had occurred. Afterward the diagnosis, he was treated with anti-inflammatory drugs, anticonvulsants and antidepressants and had undergone nerve blocks 10 times before being examined at our clinic. When the pain worsened, he was prescribed a narcotic analgesic, in spite of which he complained of pain of more than 5 on the numeric rating scale (NRS), depression, and anxiety. Although he had received treatments such as medications and nerve blocks, the pain had not decreased under a NRS score of 5, even reaching a NRS score of 8 on occasion. Also, long-term therapy and medication had led to depression and anxiety. On the first visit, he was taking an anticonvulsant (Gabapentin) 2700 mg/day, a trycyclic antidepressant (amitriptyline hydrochloride) 10 mg/day, and an analgesic (tramadol hydrochloride) 50 mg as required. At the first examination in our clinic, he complained of severe pain and hypersensitivity when his 4^th and 5^th toes were touched just slightly and of dyspepsia, rash, and depression.

During the treatment period at our clinic, which ran from January 2, 2014, to April 10, 2014, the patient underwent 14 treatments.

The patient first visited Dunsan Korean Medicine Hospital on December 14, 2013, and started receiving injection of sweet BVP from January 2, 2014. The skin test showed a negative reaction. The acupuncture point was GB43, near the tender point, and the dosage of bee venom was gradually increased from 0.15 to 0.4 mL. The initial plan was once a week for 10 weeks, but as the treatment progressed, we added the treatment period was extended to 14 weeks.

At the first treatment, the dosage of the BVP was 0.15 mL, at the second treatment, it was 0.2 mL, and at the third treatment, it was 0.3 mL. As the dosage of 0.3 mL induced no side effect, the dosage was kept at 0.3 mL until the 8^th treatment. For the remaining treatment after the 8^th , it was increased to 0.4 mL (Fig 1).

Fig. 1. Dosage of bee venom.

No side effects appeared after the first injection. The irritation decreased, but no change in the NRS score was noted. On the 2^nd day of treatment, the patient reduced Gabapentin from 2700 to 900 mg/day, though the NRS score still persisted. On the 4^th day of treatment, the average NRS score declined from 5 to 3, and the sharpest pain appeared just once or twice a week, with rare sudden pain. On the 5^th day of treatment, the sharpest pain fell from NRS 7 to 3. After that treatment, the patient experienced pain to a regular degree without sudden severe pain. After the 7^th day of treatment, he reduced the dosage of Gabapentin from 900 to 600 mg/day for 2 weeks, but upon feeling discomfort, increased it to 900 mg/day again. On the 10^th day of treatment, he reduced the dosage to 300 mg/day and experienced no increase in pain after that. On the 11th day of treatment, he discontinued taking amitriptyline hydrochloride. While insomnia and anxiety arose without the trycyclic antidepressant, he took additional herbal medicine, Ondam-tanggami (Wendan-tangjiawei). On the 13^th day of treatment, he stopped taking all western medicines. After the 14^th treatment, the last injection, the average NRS score was 1 to 2. On the NRS, the patient rated his pain as 0 after the 2-months and the 4-months follow-ups (May 30 and of July 31, 2014). No additional symptoms have occurred (Table 1), (Fig 2).

Table. 1. Date of treatment and dosage of medicine, and adverse events.

Treatment	Date	Gabapentin (mg/day)	Amitriptyline (mg/day)	Other Medicine	Adverse Events
1st	1/2	2700	10	None	None
2nd	1/9	2700	10	None	None
3rd	1/16	900	10	None	None
4th	1/23	900	10	None	None
5th	1/29	900	10	None	None
6th	2/8	900	10	None	None
7th	2/15	600	10	None	None
8th	2/22	600	10	None	None
9th	2/28	900	10	None	None
10th	3/7	600	10	None	None
Observation	3/14	300	10	None	None
11th	3/21	300	10	None	None
Observation	3/25	300	10	Ondam-tanggami	Insomnia and Anxiety (After Stopping Amitriptyline)
12th	3/27	300	0	Ondam-tanggami	Insomnia and Anxiety
13th	4/3	300	0	None	None
14th	4/10	0	0	None	None
Observation	4/24	0	0	None	None
Observation	5/30	0	0	None	None
Observation	7/31	0	0	None	None

Fig. 2. Variations in pain during the treatment period.

During the 14 treatments, no side effects due to bee venom were observed; however, insomnia and anxiety developed while reducing western medicines. Especially, at the 11^th treatment, the patient noted insomnia and anxiety after discontinuing amitriptyline hydrochloride. He took herbal medicine for 2 weeks, after which those symptoms were relieved, with no further occurrence. After the 14^th treatments, the pain had disappeared at the surgical site, and the sensation in the 4^th and the 5^th left toes was 80% that in the 4^th and the 5^th right toes (Table 1).

3. Discussion

We administered 0.15 mL of sweet BVP initially, but because the duration of the disease had been long and the pain control had been difficult, the dosage was increased gradually to 0.4 mL (Fig 1) We checked for any side effects while increasing the dosage. Although the patient felt stiffness at the injection point on the foot, a dosage under 0.3 mL was considered to be appropriate.

The initial plan was for one injection to be given each week for 10 weeks, which was based on the experience of the therapist. After 10 treatments and 2 weeks of observation, although his pain level on the NRS was 2 and he felt no inconvenience in daily living, we decided to perform four additional injections until the symptoms disappeared.

On the 10^th day of treatment, the pain had decreased to an average NRS score of 2, and on the 13^th day of treatment, the patient noted pain relief without any medication. Especially, on the 14^th day of treatment, of the last treatment, pain had disappeared, and just a little paresthesia was noted. Neither recurrence nor additional symptoms were observed during the 4-month follow-up.

We could relieve the symptoms with 10 treatments, but they had completely disappeared after the four additional treatments. Thus, we recommend that the treatment plan be based on 10 treatments, with the possibility of about 5 additional treatments, depending on the state of the patient.

The patient additionally complained of insomnia and anxiety during the course of treatment, the 11^thday. He had undergone depression because of persistent pain and failure to control the pain associated with CRPS. As the insomnia and anxiety were thought to be symptoms caused by discontinuing the nervous system drugs which he had taken for the last 7 years, we administered herbal medicine. He reported that it irritated him, but not strongly, and the insomnia and anxiety disappeared after 2 weeks. A period for discontinuing medication that has been taken for a long time, rather herbal medicine, seems to be needed.

No new systemic symptoms appeared following the treatment, and no additional medication was prescribed, except for the herbal medicine Ondam-tanggami (Wendan-tangjiawei) used for insomnia and anxiety and the intermittent herbal medicine Sojukgunbihuan (xiaojijianpiwan) used for dyspepsia.

Due to the fact that there are few distinct treatments for CRPS, many studies on anti-inflammatory drugs, nerve blocks, vitamin therapy, and acupuncture for treating patients with CRPS [11, 12]. Among those, a study on bee venom therapy is now ongoing, and it has been proven with rodents that bee venom alleviates thermal hyperalgesia [13]. Also, a chemotherapy-induced peripheral neuropathic pain model [14] and clinical research [15, 16] have already established the effect of bee venom therapy. Although these studies are not related to CRPS, they do show the effectiveness of using bee venom to treat neuropathic disease. Thus, using bee venom therapy to treat patients with CRPS should hold promise.

In the present case, bee venom therapy administered to a patient who had been suffering from CRPS with failure to control its pain for almost 7 years proved to be effective. However, the exact mechanism and therapy methods are beyond the limits of this case report. We particularly suggest further studies on the required length of the treatment and the dosage for bee venom therapy, clinical observations of bee venom therapy, and studies on the mechanisms of bee venom therapy applied to neuropathy.